Cargando…

Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer’s Disease and Inflammation at the Pre- and Early Stages of Dementia

BACKGROUND: Understanding how dysregulation in lipid metabolism relates to the severity of Alzheimer‘s disease (AD) pathology might be critical in developing effective treatments. OBJECTIVE: To identify lipid species in cerebrospinal fluid (CSF) associated with signature AD pathology and to explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teitsdottir, Unnur D., Halldorsson, Skarphedinn, Rolfsson, Ottar, Lund, Sigrun H., Jonsdottir, Maria K., Snaedal, Jon, Petersen, Petur H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203241/ https://www.ncbi.nlm.nih.gov/pubmed/33814423 http://dx.doi.org/10.3233/JAD-200964

Ejemplares similares

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
por: Teitsdottir, Unnur D., et al.
Publicado: (2020)

Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects
por: Teitsdottir, Unnur D., et al.
Publicado: (2022)

Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial–Mesenchymal Transition and Responds to Oxidative Stress
por: Wang, Qiong, et al.
Publicado: (2021)

EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
por: Choudhary, Kumari Sonal, et al.
Publicado: (2016)

Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification
por: McGarrity, Sarah, et al.
Publicado: (2018)

Obesity modulates the association between sleep apnea treatment and CHI3L1 levels but not CHIT1 activity in moderate to severe OSA: an observational study
por: Teitsdottir, Unnur Dilja, et al.
Publicado: (2018)

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
por: Karvelsson, Sigurdur Trausti, et al.
Publicado: (2021)

Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia
por: Arason, Ari Jon, et al.
Publicado: (2019)

Ion Mobility Derived Collision Cross Sections to Support Metabolomics Applications
por: Paglia, Giuseppe, et al.
Publicado: (2014)

Understanding the Causes and Implications of Endothelial Metabolic Variation in Cardiovascular Disease through Genome-Scale Metabolic Modeling
por: McGarrity, Sarah, et al.
Publicado: (2016)

Cerebrospinal fluid catecholamines in delirium and dementia
por: Henjum, Kristi, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021)

Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes
por: Trotti, Lynn Marie, et al.
Publicado: (2021)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
por: Spitzer, Philipp, et al.
Publicado: (2011)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Cerebrospinal Fluid Protein Profiles in Alzheimer’s Dementia Patients: A Bioinformatic Approach
por: Misra, Anamika, et al.
Publicado: (2023)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Cerebrospinal fluid analysis in individuals with diabetes-related dementia
por: Kanetaka, Hidekazu, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018)

Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies
por: Foska, Aikaterini, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease
por: Casoli, Tiziana, et al.
Publicado: (2019)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
por: van de Beek, M., et al.
Publicado: (2020)

deltaNp63 Has a Role in Maintaining Epithelial Integrity in Airway Epithelium
por: Arason, Ari Jon, et al.
Publicado: (2014)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Kynurenic Acid Levels in Cerebrospinal Fluid from Patients with Alzheimer’s Disease or Dementia with Lewy Bodies
por: Wennström, Malin, et al.
Publicado: (2014)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
por: Romani, Arianna, et al.
Publicado: (2020)

TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER
por: Djirackor, Luna, et al.
Publicado: (2020)

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia
por: van Wijk, Nick, et al.
Publicado: (2017)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2014)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdgimhd94mcoqdqnae918n4c62